Researchers from the Mayo Clinic and other institutions conducted a study to determine the feasibility and efficacy of circulating tumor DNA (ctDNA) profiling for the diagnosis of pancreatic ductal adenocarcinoma.

Read more: https://www.docwirenews.com/hematology-oncology/utilizing-liquid-biopsy-to-diagnose-pancreatic-cancer/